SCHEMBL5373500

SCHEMBL5373500

Nc1ccc(SCc2ccc3ccccc3n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 2/20 0.49
CYSLTR1 Q9Y271 2/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
CYP3A4 P08684 2/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GMNN O75496 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
THPO P40225 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PDE10A Q9Y233 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10546745 0.86 CYSLTR2 (0.50) CYSLTR2CYSLTR1KMT2ANPC1RAB9A
SCHEMBL7456253 0.84 CYSLTR1 (0.49) CYSLTR2CYSLTR1MEN1KMT2ANPC1
SCHEMBL7455761 0.84 CYSLTR2 (0.49) CYSLTR2CYSLTR1NPC1RAB9ACYP3A4
Hydrogen Sulfide SCHEMBL9818421 0.83 CYSLTR1 (0.48) CYSLTR2CYSLTR1MEN1KMT2ANPC1
SCHEMBL9719792 0.79 CYP1A2 (0.44) CYSLTR2CYSLTR1KMT2ACYP3A4KDM4E
SCHEMBL14021859 0.78 CYSLTR1 (0.58) CYSLTR2CYSLTR1MEN1KMT2ANPC1
SCHEMBL2877991 0.75 CYSLTR1 (0.52) CYSLTR2CYSLTR1KDM4EPDE10ANCF1
SCHEMBL3389504 0.75 KDM1A (0.53) MEN1KMT2ANPC1RAB9ACYP3A4
SCHEMBL7460680 0.74 CYP1A2 (0.43) CYSLTR2CYSLTR1CYP3A4KDM4ESMN1; SMN2
SCHEMBL7714637 0.74 CYSLTR1 (0.43) CYSLTR2CYSLTR1CYP3A4KDM4EPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD CYSLTR2 3459/4885CYSLTR1 3338/4885MEN1 4855/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD CYSLTR2 3464/4885CYSLTR1 3318/4885MEN1 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.